M30 Effect of dose reductions and/or interruptions on the efficacy of nintedanib in patients with idiopathic pulmonary fibrosis (ipf): subgroup analysis of the inpulsis trials
暂无分享,去创建一个
S. Stowasser | W. Sakamoto | T. Maher | D. Koschel | W. Wuyts | Y. Inoue | AH Hajari Case